Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshinori Nakagawa is active.

Publication


Featured researches published by Yoshinori Nakagawa.


Cancer Immunology, Immunotherapy | 1993

In vivo and in vitro activation of macrophages with a cyanine photosensitizing dye, platonin

Yoshinori Nakagawa; Sadamu Homma; Itaru Yamamoto; Masaru Banno; Hiroaki Nakazato; Hajime Imanaga; Nobuto Yamamoto

A cyanine photosensitizing dye, platonin, is a potent macrophage-activating agent. Four days after the administration to mice of small amounts of platonin (20–40 ng/mouse), peritoneal macrophages exhibited greatly enhanced Fc-receptor-mediated phagocytic and superoxide-generating capacities. Much higher doses (more than 3000 ng/mouse) did not have this effect. Photodynamic experiments for macrophage activation were performed by exposing mouse peritoneal cells (mixture of macrophages and B and T lymphocytes) to white fluorenscent light (3 J m−2s−1) in media containing various low concentrations of platonin. A short exposure to white fluorescent light (5 s, 15 J m−2) of peritoneal cells in a medium containing 3 ng platonin/ml produced a maximal level of phagocytic capacity of macrophages. Although platonin absorbs light poorly at wavelengths longer than 630 nm, the region of the spectrum in which the tissues are transparent allows reasonable penetration of light. Thus, we designed experiments in which peritoneal cells were exposed to a red fluorescent light (0.5 J m−2s−1). In a medium containing 10 ng platonin/ml with 15 J m−2 red light, a markedly enhanced ingestion activity of macrophages was observed. Photodynamic treatment of peritoneal macrophages alone did not activate macrophages. Thus, participation of nonadherent cells is required for photodynamic activation of macrophages, implying that a macrophage-activating factor is generated within the nonadherent cells and transmitted to macrophages.


Advances in Experimental Medicine and Biology | 2010

Design of Novel Hypoxia-Targeting IDO Hybrid Inhibitors Conjugated with an Unsubstituted L-TRP as an IDO Affinity Moiety

Hitomi Nakashima; Kazuhiro Ikkyu; Kouichiro Nakashima; Keiichiro Sano; Yoshihiro Uto; Eiji Nakata; Hideko Nagasawa; Hiroshi Sugimoto; Yoshitsugu Shiro; Yoshinori Nakagawa; Hitoshi Hori

We presented here design, syntheses and inhibitory activities of novel hypoxia-targeting IDO hybrid inhibitors conjugated with an unsubstituted L-Trp as an IDO affinity moiety without inhibitor 1MT, such as L-Trp-TPZ hybrids 1 (TX-2274), 2 (UTX-3), 3 (UTX-4), and 4 (UTX-2). TPZ-monoxide hybrids 1 and 3 were good competitive IDO inhibitors, while TPZ hybrids 2 and 4 were uncompetitive IDO inhibitors. Among them TPZ-monoxide hybrid 1 have the strongest IDO inhibitory activity. It suggests that TPZ-monoxide hybrids 1 and 3 are able to bind the active site of IDO, TPZ hybrids 2 and 4 are able to bind the enzyme-substrate complex. We proposed the possible mechanism of action of TPZ hybrid 2 that may first affect as a hypoxic cytotoxin, and then metabolized to TPZ-monoxide hybrid 1, which may do as an IDO inhibitor more effectively than its parent TPZ hybrid 2.


Journal of the society of cosmetic chemists | 1985

Assay for KANKOH-SO No. 401 by Titration Method by Tetraphenylboron with Bromophenol Blue as an Indicator Reagent

Yoshinori Nakagawa; Toshiko Suda; Tsuyoshi Kani; Itaru Yamamoto

A simple and rapid titration method for KANKOH-SO No. 401 has been developed. KANKOH-SO No. 401 reacted with bromophenolblue (BPB) and formed a complex, which was extacted to chloroform. When tetraphenylborone (TPB) was added to this solution, TPB and KANKOH-SO No. 401 interacted quantitatively and BPB was found to be released from chloroform phase to water.Therefore, condition were established to determine KANKOH-SO No. 401 by titration method with TPB in the presence of small amounts of BPB as an indicator reagent.


Biological & Pharmaceutical Bulletin | 1993

Characteristic Bleaching Profiles of Cyanine Dyes Depending on Active Oxygen Species in the Controlled Fenton Reaction

Yoshinori Nakagawa; Hitoshi Hori; Itaru Yamamoto; Hiroshi Terada


Anticancer Research | 2003

Gc protein-derived macrophage activating factor (GcMAF): Isoelectric focusing pattern and tumoricidal activity

Saharuddin B. Mohamad; Hideko Nagasawa; Hideyuki Sasaki; Yoshihiro Uto; Yoshinori Nakagawa; Ken Kawashima; Hitoshi Hori


Anticancer Research | 2012

β-Galactosidase treatment is a common first-stage modification of the three major subtypes of Gc protein to GcMAF.

Yoshihiro Uto; Syota Yamamoto; Hirotaka Mukai; Noriko Ishiyama; Ryota Takeuchi; Yoshinori Nakagawa; Keiji Hirota; Hiroshi Terada; Shinya Onizuka; Hitoshi Hori


Anticancer Research | 2011

Effect of the Gc-derived Macrophage-activating Factor Precursor (preGcMAF) on Phagocytic Activation of Mouse Peritoneal Macrophages

Yoshihiro Uto; Syota Yamamoto; Ryota Takeuchi; Yoshinori Nakagawa; Keiji Hirota; Hiroshi Terada; Shinya Onizuka; Eiji Nakata; Hitoshi Hori


Biological & Pharmaceutical Bulletin | 1998

Inhibitory effects of pentamethine trinuclear cyanine dyes on ADP/Fe2+-induced lipid peroxidation in rat liver mitochondria : Changes in the mode of action with the hydrophobic nature of the dyes

Kentaro Kogure; Hironori Sassa; Kazutoyo Abe; Katsuyuki Kitahara; Yuka Sano; Hideto Kawano; Yoshinori Nakagawa; Hiroshi Terada


Archive | 2011

PROCESS FOR PRODUCTION OF NOVEL DEGALACTOSYLATED GC GLOBULIN

Hitoshi Hori; Yoshihiro Uto; Ryota Takeuchi; Yoshinori Nakagawa; Hiroshi Terada; Keiji Hirota


Anticancer Research | 2013

Antitumor Effect of Degalactosylated Gc-Globulin on Orthotopic Grafted Lung Cancer in Mice

Keiji Hirota; Yoshinori Nakagawa; Ryota Takeuchi; Yoshihiro Uto; Hitoshi Hori; Shinya Onizuka; Hiroshi Terada

Collaboration


Dive into the Yoshinori Nakagawa's collaboration.

Top Co-Authors

Avatar

Hiroshi Terada

Tokyo University of Science

View shared research outputs
Top Co-Authors

Avatar

Hitoshi Hori

University of Tokushima

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Keiji Hirota

Tokyo University of Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hideko Nagasawa

Gifu Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Hideto Kawano

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge